Phase 2 Trial Of S-531011 With RadScopal In Previously Treated Metastatic Colorectal Cancer

by | Jul 24, 2026 | Clinical Trials | 0 comments

​ Conditions: Phase II; S-531011; RadScopal; Metastatic Colorectal Cancer

Interventions: Drug: S-531011; Radiation: HD-XRT

Sponsors: M.D. Anderson Cancer Center

Not yet recruiting Conditions: Phase II; S-531011; RadScopal; Metastatic Colorectal Cancer
Interventions: Drug: S-531011; Radiation: HD-XRT
Sponsors: M.D. Anderson Cancer Center
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *